Fosun Develops Business for Good and Creates IMPACT
Rhea-AI Summary
Fosun International (FOSUY) has released its 2024 ESG Report and third Climate Information Disclosures Report, highlighting its commitment to sustainable development. The company maintained an MSCI ESG rating of AA and ranked in the top 5% among global peers in S&P Global's Corporate Sustainability Assessment.
The company has established concrete climate goals, aiming to peak carbon emissions by 2028 and achieve carbon neutrality by 2050. Notable achievements include completing a USD888 million sustainability-linked syndicated loan and maintaining LEED Platinum certification for the Bund Finance Center in Shanghai.
In healthcare innovation, Fosun's anticancer drug HANSIZHUANG received EU approval for small cell lung cancer treatment, while their artesunate injection has treated over 80 million severe malaria patients globally. The company's total assets reached RMB796.5 billion as of December 2024.
Positive
- Maintained MSCI ESG rating of AA and ranked in top 5% among global peers
- Secured USD888 million sustainability-linked syndicated loan
- HANSIZHUANG received EU approval for cancer treatment
- Artesunate injection treated over 80 million malaria patients globally
- Total assets reached RMB796.5 billion
Negative
- None.
Releases 2024 ESG Report and the Third Climate Information Disclosures Report
With the original aspiration of "Self-improvement, Teamwork, Performance, and Contribution to Society", Fosun firmly believes in its commitment to developing business for good. While strengthening its business operations, Fosun continuously refines its sustainable development strategy to address changes in the global economy, society, and environment, ensuring long-term competitiveness while creating social value. Last year, Fosun formulated its sustainable development strategy, focusing on six key directions under "Create IMPACT", which stands for I: Innovation-driven, M: Mindful Operation, P: People and Partner Oriented, A: Advanced Governance, C: Climate and Planet Positive and T: Transparency.
Actively driving global sustainable development and achieving outstanding ESG ratings
In 2024, Fosun continued to focus on its core businesses. By leveraging its increasingly sophisticated global business presence, it operated responsibly across more than 35 countries and regions, actively contributing to public welfare and creating sustainable value worldwide. Fosun has long been dedicated to philanthropy projects in areas such as rural revitalization, healthcare, educational equity, community construction, culture and art, significantly expanding its impact across global communities and striving to build a more responsible, inclusive and sustainable future.
As a responsible global citizen, Fosun officially joined the United Nations Global Compact ("UN Global Compact") in 2014. It fully supports the ten principles of the UN Global Compact on human rights, labor, environment and anti-corruption, and has deeply integrated these principles into its "Create IMPACT" sustainable development strategy and code of conduct. Over the past year, despite the global environmental, social and economic uncertainties, Fosun remained committed to sustainable development, diligently upholding its long-term commitments in key areas of sustainable development, and achieving good results. Fosun International maintained an MSCI ESG rating of AA, achieved an HSI ESG rating of AA-, ranked in the top
Actively responding to climate change and promoting low-carbon transformation
In response to climate change, the Group has transitioned from passive adaptation to active participation and innovation. At the top-level organizational structure, under the guidance of the Board of Directors (the "Board") and the Carbon Neutrality Committee, Fosun International has achieved several key phased goals, such as incorporating carbon neutrality indicators into the performance appraisal of the management, establishing a carbon emission management system and audit standards, and conducting greenhouse gas inventory training across the Group. In terms of technology-driven low-carbon transformation, the Group has accelerated the adoption of low-carbon technologies, leveraging innovative technologies to drive the low-carbon transformation of the industrial chain and provide consumers with more sustainable products and services. In terms of financial innovation, in 2024, the Group successfully completed a sustainability-linked syndicated loan amounting to
Fosun actively responds to the national "dual carbon" goals by promoting carbon neutrality and energy conservation and emission reduction. In 2021, Fosun made a commitment to society – "strive to peak carbon emissions by 2028 and achieve carbon neutrality by 2050". Fosun has formulated strategies for climate change mitigation and adaptation to align with the 1.5°C temperature control target set in the Paris Agreement. As 2024 marked the final year before Hong Kong Stock Exchange's New Climate Requirements came into effect, Fosun International proactively aligned with international standards such as TCFD and IFRS S2, and released its third Climate Information Disclosures Report, enhancing the transparency of its climate actions and demonstrating its commitment to ongoing efforts in this area.
The Group also actively encourages its member companies to carry out climate actions. The Bund Finance Center (BFC), the Group's base in
In 2024, Fosun Insurance Portugal (Fidelidade) participated in the 29th session of the Conference of the Parties (
Leveraging innovation to actively contribute to society
Fosun adheres to the innovation-driven strategy, and the anticancer and antimalarial drugs developed by its health industries have widely benefited cancer patients and severe malaria patients. Henlius' innovative drug, HANSIZHUANG (serplulimab injection), an anti-PD-1 monoclonal antibody, was approved for marketing in the European Union in early 2025. This milestone makes it the first and only PD-1 innovative drug approved for the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC) in the European Union. As of the end of 2024, Fosun Pharma's independently developed artesunate for injection had saved more than 80 million severe malaria patients worldwide, with more than 400 million doses supplied globally.
In the Chinese mainland, Fosun Kairos' first CAR-T cell therapy product, Yi Kai Da (ejilunsai injection), had benefited over 800 lymphoma patients as of the end of 2024. Additionally, Intuitive Fosun's Ion Robotic Bronchoscopy ("Ion System") was approved by the National Medical Products Administration in 2024. Fosun has been actively fostering global win-win cooperation to enhance the accessibility and affordability of medical technologies, ensuring that more patients can benefit.
In order to better promote the fulfilment and implementation of corporate social responsibility, Fosun Foundation was established in 2012. It has been making unremitting efforts in the fields of global emergency relief, rural revitalization, health, education, culture and art, youth development, etc. to create social value. Among these initiatives, the Rural Doctors Program has supported 25,000 rural doctors and benefited 3 million rural families since its launch in 2017. Moreover, the "Rural Doctors Program Empowering Rural Medical Services" was included in the "20 Cases of Private Sector's Sustainable Development in
Regarding youth entrepreneurship and development, under the principle of "Innovation and People-oriented Development", Fosun Foundation, in collaboration with Fidelidade and
Linking ESG performance to Board appraisal through a top-down, long-term ESG mechanism
Fosun has established a top-down and long-term mechanism for ESG improvement and has included ESG management performance as an evaluation factor in the Executive Directors' performance assessment, and the ESG management performance appraisal mechanism is also extended to the CEOs of the Group and the personnel in charge of each business group. Fosun has set up an ESG Board Committee under the Board to assist the Board in guiding and overseeing the Group's ESG development and implementation. At the management and decision level, Fosun has established an ESG Executive Committee under the management to provide decision support for the implementation of ESG strategies. At the implementation level, the Group has also set up an ESG Management Committee and an ESG Working Group to implement ESG strategies and related actions and ensure the establishment of appropriate and effective ESG risk management and internal control system.
Looking ahead, Fosun will continue to keep abreast of the development of the global sustainable development field, refine and enhance Fosun's ESG management, actively respond to national strategies, implement "dual carbon" goals, promote rural revitalization, expand impact across global communities in areas such as healthcare, educational equity, community construction, culture and art. In operational management, Fosun will continue to promote initiatives such as ensuring information security, promoting technology innovation, and protecting employees' rights and interests, which collectively drive the integration of sustainable practices and value creation. Leveraging the resources and advantages of Fosun's global industrial ecosystem, Fosun endeavours to create a positive impact on sustainable development and continuously create a better world.
- End -
For more information on Fosun's ESG, please refer to Fosun International's ESG Report 2024 posted on the Hong Kong Stock Exchange's website (http://www.hkexnews.hk)
or the Company's ESG webpage (https://en.fosun.com/esg/)
The electronic copy of the 2024 Climate Information Disclosures Report is available on the Company's ESG webpage: (https://en.fosun.com/esg/)
About Fosun
Fosun was founded in 1992. After more than 30 years of development, Fosun has become a global innovation-driven consumer group. Adhering to the mission of creating happier lives for families worldwide, Fosun is committed to creating a global happiness ecosystem fulfilling the needs of families worldwide in Health, Happiness, and Wealth. In 2007, Fosun International was listed on the main board of the Hong Kong Stock Exchange (stock code: 00656.HK). As of 31 December 2024, Fosun International's total assets amounted to
View original content:https://www.prnewswire.com/news-releases/fosun-develops-business-for-good-and-creates-impact-302438401.html
SOURCE Fosun